Metraipolis › archive › dc_9acc2fc702f4
Dual function antibody targeting αvβ3 and PD-L1 provide a promising strategy for solid tumor therapy — Europe PMC PMID:41601637
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41601637
- DOI
- 10.3389/fimmu.2025.1691774
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T22:01:14.342Z
- SHA-256 of the archived text
5ef8ac194110f406c510104f6aace1cae75c237dadf17816d766d42bcfe6500c- Stable URL of this page
https://metraipolis.com/documento/dc_9acc2fc702f4
How to cite
Dual function antibody targeting αvβ3 and PD-L1 provide a promising strategy for solid tumor therapy — Europe PMC PMID:41601637 — Europe PMC (en), https://europepmc.org/article/MED/41601637 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9acc2fc702f4 (Metraipolis archive dc_9acc2fc702f4, sha256 5ef8ac194110f406c510104f6aace1cae75c237dadf17816d766d42bcfe6500c)
BibTeX
@misc{dc9acc2fc702f4,
title = {Dual function antibody targeting αvβ3 and PD-L1 provide a promising strategy for solid tumor therapy — Europe PMC PMID:41601637},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41601637},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9acc2fc702f4; sha256 5ef8ac194110f406c510104f6aace1cae75c237dadf17816d766d42bcfe6500c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41601637. Agents can read the archived copy with the MCP tool read_document.